Sulfobutyl Ether Beta Cyclodextrin Sodium for Injection | SBECD Pharmaceutical Excipient

Sulfobutyl Ether Beta Cyclodextrin Sodium for Injection | SBECD Pharmaceutical Excipient

Sulfobutyl Ether Beta Cyclodextrin Sodium for Injection | SBECD Pharmaceutical Excipient
CAS No.: 182410-00-0
Other Name: Sulfobutyl Ether Beta Cyclodextrin Sodium; SBECD; SBE-β-CD
Appearance: White to off-white amorphous powder
Molecular Formula: C42H70-nO35(C4H8SO3Na)n
Average Degree of Substitution: 6.2–6.9
Shelf Life: 36 Months
Grade: Injectable Pharmaceutical Grade
Standards: USP / EP / BP / ChP
Application: Pharmaceutical Excipients
Assay: 95.0%–105.0%
Bacterial Endotoxins: <0.005 EU/mg
pH: 4.0–6.8
Package Specification: 0.5 kg/bag, 1 kg/bag, 10 kg/bag, 10 kg/drum, 20 kg/drum

    Send Inquiry

    Product Description

    ```html


    Sulfobutyl Ether Beta Cyclodextrin Sodium for Injection | SBECD Pharmaceutical Excipient

    Sulfobutyl Ether Beta Cyclodextrin Sodium SBECD Powder

    Sulfobutyl Ether Beta Cyclodextrin Sodium (SBECD), also known as Betadex Sulfobutyl Ether Sodium or SBE-β-CD, is a highly water-soluble anionic derivative of beta-cyclodextrin. It is widely used as a pharmaceutical excipient, particularly in injectable drug formulations.

    With its hydrophilic sulfobutyl ether groups and hydrophobic inner cavity, SBECD can form reversible inclusion complexes with suitable active pharmaceutical ingredients (APIs). This helps improve the apparent aqueous solubility of poorly water-soluble drugs and supports pharmaceutical formulation development.

    Key Features and Benefits of SBECD

    • High Water Solubility: Freely soluble in water, suitable for aqueous pharmaceutical formulations.
    • Drug Solubilization: Helps improve the apparent solubility of poorly water-soluble active pharmaceutical ingredients.
    • Inclusion Complex Formation: Forms reversible host-guest complexes with suitable drug molecules.
    • Injectable Applications: Used as a solubilizing excipient in selected parenteral drug formulations.
    • Quality Control: Key quality attributes, including degree of substitution, impurities and bacterial endotoxins, are monitored.

    Pharmaceutical Applications of SBECD

    1. Injectable Formulations

    SBECD is primarily used as a solubilizing excipient in injectable pharmaceutical formulations, including intravenous products. It helps improve the aqueous solubility of suitable poorly soluble APIs.

    2. Antifungal Drug Formulations

    SBECD is used in certain antifungal formulations to enhance drug solubility and support the development of aqueous dosage forms.

    3. Antiviral Drug Formulations

    Its inclusion complex-forming properties make SBECD useful in selected antiviral formulations where improved drug solubility is required.

    4. Oncology Drug Formulations

    SBECD can serve as a solubilizing excipient during the formulation development of selected poorly water-soluble oncology compounds.

    5. Pharmaceutical Research and Development

    SBECD is used in formulation research to investigate drug-cyclodextrin inclusion complexes, solubility enhancement and formulation stability.

    Product Specifications

    Product Name Betadex Sulfobutyl Ether Sodium
    Other Names Sulfobutyl Ether Beta Cyclodextrin Sodium, SBECD, SBE-β-CD
    CAS No. 182410-00-0
    Molecular Formula C42H70-nO35(C4H8SO3Na)n
    Molecular Weight 1134 + 158n
    Appearance White to off-white amorphous powder
    Grade Injectable Pharmaceutical Excipient
    Standards USP / EP
    Assay 95.0%–105.0%
    Average Degree of Substitution 6.2–6.9
    Solubility Freely soluble in water
    Bacterial Endotoxins ≤10 EU/g
    Shelf Life 36 months

    The above information provides a general product overview. Please refer to the latest product specification and batch-specific Certificate of Analysis (COA) for official acceptance criteria.

    Quality Control and Testing

    Quality consistency is essential for pharmaceutical excipients used in parenteral formulations. Our SBECD is subject to quality control procedures throughout the production process, with particular attention to the following quality attributes:

    • Identification and assay
    • Average degree of substitution (DS)
    • Related substances and process-related impurities
    • Residual 1,4-butane sultone
    • Residual beta-cyclodextrin
    • Sodium chloride content
    • Bacterial endotoxins
    • Total aerobic microbial count and yeast and mold count

    Batch-specific quality documentation, including a Certificate of Analysis (COA), is available to support customer quality evaluation and documentation requirements.

    SBECD quality control and testing

    Packaging Specifications

    SBECD is available in different packaging options to meet laboratory evaluation, formulation development and commercial production requirements.

    • 500 g/bag
    • 1 kg/bag
    • 10 kg/bag
    • 10 kg/drum
    • Other packaging options can be discussed according to customer requirements.

    SBECD pharmaceutical excipient packaging

    Company Qualifications and Experience

    Xi'an DELI Biochemical Industry Co., Ltd. was established in 1999 and has over 26 years of experience in the cyclodextrin industry. We specialize in cyclodextrins and their derivatives, including Hydroxypropyl Betadex (HPBCD) and Betadex Sulfobutyl Ether Sodium (SBECD).

    Our company operates an ISO 9001-certified quality management system and maintains quality control procedures throughout the production process to support the requirements of pharmaceutical customers.

    Relevant regulatory documentation and product registration information are available for customer evaluation, including US FDA DMF information for applicable products.

    Xi'an DELI Biochemical company qualifications and certifications

    Production Capability

    With dedicated production facilities and established process controls, Xi'an DELI Biochemical provides SBECD for pharmaceutical development and commercial applications.

    Our annual production capacity exceeds 200 metric tons, with a typical batch size of approximately 2.5 metric tons. This production capability supports batch supply and long-term cooperation with pharmaceutical customers worldwide.

    SBECD production facilities and production capability

    Frequently Asked Questions (FAQ)

    Q1: What is SBECD used for in pharmaceutical formulations?
    A: SBECD is primarily used as a solubilizing excipient. It forms inclusion complexes with suitable drug molecules to improve the apparent aqueous solubility of poorly water-soluble APIs.


    Q2: What is the CAS number of SBECD?
    A: The CAS number of Betadex Sulfobutyl Ether Sodium is 182410-00-0.


    Q3: What is the average degree of substitution of your SBECD?
    A: Our product has an average degree of substitution of 6.2–6.9, according to the applicable product specification.


    Q4: Is SBECD suitable for injectable pharmaceutical formulations?
    A: SBECD is primarily used as a pharmaceutical excipient in selected injectable formulations. Its suitability for a specific drug product should be evaluated according to formulation requirements and applicable regulatory standards.


    Q5: Which pharmacopoeial standards does your SBECD follow?
    A: Our SBECD product is tested according to applicable USP and EP requirements. Please contact us for the latest specification and COA.


    Q6: Can you provide a DMF and technical documentation?
    A: Relevant regulatory and technical documents, including available DMF information, product specifications and COA, can be provided for customer evaluation.


    Q7: Can you provide samples for formulation development?
    A: Yes. Samples can be discussed for pharmaceutical research, formulation development and product evaluation.


    Contact Us for SBECD

    Looking for Betadex Sulfobutyl Ether Sodium (SBECD), CAS 182410-00-0, for injectable pharmaceutical applications?

    Contact Xi'an DELI Biochemical Industry Co., Ltd. for product specifications, COA, technical documentation, samples and quotations. We welcome inquiries from pharmaceutical companies, formulation developers and pharmaceutical excipient distributors worldwide.

    Company: Xi'an DELI Biochemical Industry Co., Ltd.
    Website: https://www.delicydextrin.com/
    Email: stella@xadl.com






    Related Category

    Send Inquiry

    Please Feel free to give your inquiry in the form below. We will reply you in 24 hours.
    icon
    X
    We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
    Reject Accept